1-Year Fixed-Regimen Bevacizumab Treatment in DME-Vascular Network Image Analysis in Optical Coherence Tomography Angiography Study
Purpose: To evaluate the effectiveness of intravitreal bevacizumab treatment in patients with diabetic macular edema (DME) by assessing retinal changes using AngioTool software (version 0.6a(02.18.14), National Cancer Institute, Bethesda, Maryland). Methods: A total of 27 eyes in patients with treat...
Main Authors: | Magdalena Hunt, Adam Wylęgała, Edward Wylęgała, Sławomir Teper |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/8/2125 |
Similar Items
-
How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients
by: Bogumiła Sędziak-Marcinek, et al.
Published: (2021-08-01) -
Effect of a Fixed Combination of Curcumin, Artemisia, Bromelain, and Black Pepper Oral Administration on Optical Coherence Tomography Angiography Indices in Patients with Diabetic Macular Edema
by: Flavia Chiosi, et al.
Published: (2022-04-01) -
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
by: Ribeiro de Carvalho G, et al.
Published: (2020-09-01) -
Retinal Vascular Study Using OCTA in Subjects at High Genetic Risk of Developing Alzheimer’s Disease and Cardiovascular Risk Factors
by: Inés López-Cuenca, et al.
Published: (2022-06-01) -
Timing of administration of Conbercept in the treatment of SNPDR with DME in PRP
by: Yan Zhang, et al.
Published: (2020-11-01)